Markets:

Overview

News

Currencies

International

Treasuries

Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

7.295 -0.675 (-8.47%)

Delayed Quote Updated: 2:57 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

BLCT Stock: 7 Things to Know About LGBT Platform BlueCity Holdings and the Spriver Tech Deal ↗

January 03, 2022

BlueCity Holdings (BLCT) has announced an offer for the company's stock from Baoli Ma and Spriver Tech Limited and we've got the details.

Via InvestorPlace

IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today ↗

January 03, 2022

Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.

Via InvestorPlace

Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates ↗

January 03, 2022

Following the market opening Monday, the Dow traded up 0.11% to 36,378.68 while the NASDAQ rose 0.18% to 15,673.75. The S&P also rose, gaining 0.11% to 4,771.56. The U.S. has...

Via Benzinga

Immix Shares Rally On FDA Rare Pediatric Disease Tag For Cancer Program In Children ↗

January 03, 2022

The FDA has granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma Inc's (NASDAQ: IMMX) IMX-110 for rhabdomyosarcoma, a form of...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 03, 2022

Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 29, 2021

Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 28, 2021

Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

December 21, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

December 20, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...

Via Benzinga

65 Biggest Movers From Yesterday ↗

December 21, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 20, 2021

The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday!

Via InvestorPlace

25 Stocks Moving in Monday's Pre-Market Session ↗

December 20, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index. Verso Corporation (NYSE:...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week ↗

December 19, 2021

Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...

Via Talk Markets

The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week ↗

December 19, 2021

Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...

Via Benzinga

Opening Day: Samsara Pops In Trading Debut After IPO Raises $805M ↗

December 18, 2021

Shares of software maker Samsara rose over 7% in the stock's trading debut following a $805 million IPO. The company is the pioneer of the Connected Operations Cloud, which allows businesses to develop...

Via Talk Markets

28 Stocks Moving In Friday's Mid-Day Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 17, 2021

Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!

Via InvestorPlace

The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street ↗

December 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.